ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 122 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $463,000 | -88.4% | 76,821 | -93.1% | 0.00% | -100.0% |
| Q3 2019 | $3,984,000 | -31.4% | 1,106,750 | -49.0% | 0.00% | -33.3% |
| Q2 2019 | $5,811,000 | -37.4% | 2,168,348 | -30.9% | 0.00% | -40.0% |
| Q1 2019 | $9,282,000 | +5.7% | 3,135,806 | -43.2% | 0.01% | 0.0% |
| Q4 2018 | $8,782,000 | -43.3% | 5,522,994 | +31.2% | 0.01% | -28.6% |
| Q3 2018 | $15,488,000 | +16.5% | 4,208,555 | -10.4% | 0.01% | 0.0% |
| Q2 2018 | $13,295,000 | +23.1% | 4,697,724 | +61.4% | 0.01% | +16.7% |
| Q1 2018 | $10,796,000 | +364.3% | 2,910,063 | +260.5% | 0.01% | +500.0% |
| Q4 2017 | $2,325,000 | +194.3% | 807,144 | +358.3% | 0.00% | – |
| Q3 2017 | $790,000 | -32.0% | 176,118 | -30.4% | 0.00% | -100.0% |
| Q2 2017 | $1,162,000 | +20.8% | 253,069 | +10.8% | 0.00% | 0.0% |
| Q1 2017 | $962,000 | -42.7% | 228,502 | -43.7% | 0.00% | 0.0% |
| Q4 2016 | $1,678,000 | -43.6% | 406,201 | +10.6% | 0.00% | -50.0% |
| Q3 2016 | $2,975,000 | +286.9% | 367,176 | +272.3% | 0.00% | +100.0% |
| Q2 2016 | $769,000 | -71.0% | 98,625 | -71.3% | 0.00% | -66.7% |
| Q1 2016 | $2,656,000 | -53.7% | 344,087 | -35.3% | 0.00% | -50.0% |
| Q4 2015 | $5,736,000 | +23.6% | 531,580 | -20.9% | 0.01% | +50.0% |
| Q3 2015 | $4,642,000 | +227.1% | 671,826 | +319.7% | 0.00% | +300.0% |
| Q2 2015 | $1,419,000 | +135.7% | 160,090 | +161.9% | 0.00% | 0.0% |
| Q1 2015 | $602,000 | -5.2% | 61,125 | +18.0% | 0.00% | 0.0% |
| Q4 2014 | $635,000 | -87.6% | 51,788 | -89.9% | 0.00% | -80.0% |
| Q3 2014 | $5,107,000 | +336.1% | 511,728 | +230.8% | 0.01% | +400.0% |
| Q2 2014 | $1,171,000 | +2109.4% | 154,676 | +857.0% | 0.00% | – |
| Q1 2014 | $53,000 | -73.9% | 16,163 | -73.6% | 0.00% | – |
| Q4 2013 | $203,000 | -62.5% | 61,216 | -65.8% | 0.00% | -100.0% |
| Q3 2013 | $541,000 | -3.6% | 179,156 | +160.9% | 0.00% | 0.0% |
| Q2 2013 | $561,000 | – | 68,659 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |